Filing Flows

Filing Flows › Companies › Science Applications International › Cash flow

Science Applications International cash flow, quarter by quarter

Latest: Q2 FY27 · from the cash-flow statements filed with the SEC

Free cash flow$131M in Q2 FY27 · $619M over twelve months

Operating cash flow$146M
Capital spending−$15.0M
Free cash flow+$131M
Cash / net income1.4×

Analysis

In Q2 FY27, Science Applications International generated $146M of operating cash flow and spent $15.0M on capital projects, leaving free cash flow of $131M.

Over the twelve months to Jul 31, 2026, operating cash flow was $660M; the largest uses were net borrowing (+) / repaid (−) ($1.2B), buybacks ($479M), other investing ($199M); besides operations, cash came from other financing ($1.4B), shares issued ($20.0M); the cash balance rose by $78.0M.

Operating cash flow was $146M against net income of $102M — 1.4× profit, cash ran ahead of reported earnings. The largest differences: employee-related liabilities +$56.0M, depreciation & amortization +$39.0M, receivables −$34.0M.

Free cash flow

Science Applications International: free cash flow by quarterScience Applications International: free cash flow by quarter$134MQ3 FY25$100MQ4 FY25$92.0MQ1 FY26$115MQ2 FY26$120MQ3 FY26$250MQ4 FY26$118MQ1 FY27$131MQ2 FY27
Operating cash flow less capital spending.
Science Applications International: operating cash flow against capital spendingScience Applications International: operating cash flow against capital spendingOperating cash flowCapital spending$143M$9.0MQ3 FY25$115M$15.0MQ4 FY25$100M$8.0MQ1 FY26$122M$7.0MQ2 FY26$129M$9.0MQ3 FY26$258M$8.0MQ4 FY26$127M$9.0MQ1 FY27$146M$15.0MQ2 FY27
Latest (Q2 FY27): Operating cash flow $146M, Capital spending $15.0M.

Capital allocation, year by year

Science Applications International: where the cash came from (up) and went (down), by fiscal yearScience Applications International: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedAsset salesCapital spendingAcquisitionsBuybacksDividendsFY22: Operating cash flow $518MFY22: Net borrowing −$3.0MFY22: Shares issued $17.0MFY22: Asset sales $8.0MFY22: Capital spending −$36.0MFY22: Acquisitions −$255MFY22: Buybacks −$226MFY22: Dividends −$86.0M$543MFY22FY23: Operating cash flow $532MFY23: Net borrowing −$150MFY23: Shares issued $16.0MFY23: Capital spending −$25.0MFY23: Buybacks −$267MFY23: Dividends −$83.0M$548MFY23FY24: Operating cash flow $396MFY24: Net borrowing −$281MFY24: Shares issued $17.0MFY24: Asset sales $356MFY24: Capital spending −$27.0MFY24: Buybacks −$382MFY24: Dividends −$79.0M$769MFY24FY25: Operating cash flow $494MFY25: Net borrowing $118MFY25: Shares issued $21.0MFY25: Capital spending −$36.0MFY25: Buybacks −$558MFY25: Dividends −$75.0M$633MFY25FY26: Operating cash flow $609MFY26: Net borrowing $271MFY26: Shares issued $22.0MFY26: Capital spending −$32.0MFY26: Acquisitions −$203MFY26: Buybacks −$445MFY26: Dividends −$70.0M$902MFY26
Over these 5 years operating cash flow totalled $2.5B; the largest uses were buybacks ($1.9B) and acquisitions ($458M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$126M
Debt$2.5B
Net debt$2.4B
Due within a year$19.0M

Science Applications International funds itself: free cash flow was $619M over the last twelve months, and $126M of cash and investments stands against $2.5B of debt ($19.0M due within a year, 6.6× covered by cash).

Science Applications International: debt maturities by year (FY26)Science Applications International: debt maturities by year (FY26)$19.0MYear 1$31.0MYear 2$489MYear 3$88.0MYear 4$899MYear 5$975MAfter year 5
Principal due in each year as disclosed in the annual report, against $126M of cash and investments now.

Where the cash came from and went

Science Applications International: sources (+) and uses (−) of cash, Q2 FY27Science Applications International: sources (+) and uses (−) of cash, Q2 FY27Operating cash flow$146MBuybacks−$98.0MCash drawn (+) / kept (−)−$17.0MDividends−$16.0MCapital spending−$15.0MShares issued$5.0MOther financing−$5.0M
Science Applications International: sources (+) and uses (−) of cash, TTM to Q2 FY27Science Applications International: sources (+) and uses (−) of cash, TTM to Q2 FY27Other financing$1.4BNet borrowing (+) / repaid (−)−$1.2BOperating cash flow$660MBuybacks−$479MOther investing−$199MCash drawn (+) / kept (−)−$78.0MDividends−$67.0MCapital spending−$41.0MShares issued$20.0M

From profit to cash

Science Applications International: net income to operating cash flow, Q2 FY27Science Applications International: net income to operating cash flow, Q2 FY27Net income$102MDepreciation & amortization$39.0MStock-based pay$15.0MDeferred taxes$22.0MOther non-cash−$2.0MReceivables−$34.0MPayables−$25.0MEmployee-related liabilities$56.0MPrepaid and other assets−$29.0MOther liabilities$3.0MOperating cash flow$146M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.

Every quarter

QuarterOperating cash flowCapital spendingBuybacksDividendsNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q2 FY27$146M−$15.0M−$98.0M−$16.0M—$5.0M−$17.0M$131M
Q1 FY27$127M−$9.0M−$188M−$17.0M—$5.0M$73.0M$118M
Q4 FY26$258M−$8.0M−$98.0M−$17.0M−$1.0M$6.0M−$137M$250M
Q3 FY26$129M−$9.0M−$95.0M−$17.0M$1.4B$4.0M$3.0M$120M
Q2 FY26$122M−$7.0M−$110M−$17.0M$557M$6.0M−$1.0M$115M
Q1 FY26$100M−$8.0M−$142M−$19.0M$61.0M$6.0M$9.0M$92.0M
Q4 FY25$115M−$15.0M−$133M−$18.0M−$325M$6.0M−$10.0M$100M
Q3 FY25$143M−$9.0M−$121M−$18.0M−$9.0M$5.0M$2.0M$134M

Science Applications International: income statement and cash flow

Science Applications International, Q2 FY27: revenue $1.9B (+6% year over year), operating margin 8.1%. The chart follows the revenue to costs, profit and cash.

Science Applications International: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.